Transaction · 0001578852-26-000024

Boulding Mark Elliott

Boulding Mark Elliott, EVC, reported a transaction classified as exercise at PTC THERAPEUTICS, INC. involving 435.000000 shares for an estimated $17147.70. Reported holdings after the transaction were 105707.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MEVC
PTCTPTC THERAPEUTICS, INC.
Filing timeOct 07
Trade dateOct 06, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableCalculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$63.23
Pre-filing
1mo ago +9.6%1w ago +2.7%1d ago +0.7%
Returns since
7d30d90d180d1y

PTCT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
PTCT since 2026-10-07Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001578852-26-000024
Common Stock
Transaction date
Oct 06, 2026
Filed Oct 07, 2026, 09:20 PM · 1d delay
Shares
435 sh
$39.42 per share
Estimated value
$17.1k
Computed from shares × price
Holdings after
105k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EXEC. VP AND CLO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025.

  2. F2

    This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.00 to $64.34 per share. The Reporting Person hereby undertakes, u…

  3. F3

    This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.00 to $64.90 per share. The Reporting Person hereby undertakes, u…

  4. F4

    This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares…

Original filing · 0001578852-26-000024
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

PTCT